[ad_1]
The vaccine CoronaVac did not reach 90% effectiveness in tests carried out in Brazil, according to the state health secretary of Saint Paul, Jean Gorinchteyn. The announcement was made on Thursday (24) and differs from what was revealed by Turkey. The percentage obtained should have been announced last Wednesday (23) by the Butantan Institute, but, according to the institute, the disclosure was postponed at the request of the Chinese laboratory Sinovac. The information is from the G1 portal.
“To give you an idea, the flu vaccine has a variation, according to each age group, of protection, which goes from 40% to 80% in certain groups. So we knew that the efficiency would never reach 90%. But what we do not imagine is that the company wanted, and aimed, a unit, a very close result in all countries, and not only in one or another country “, declared the secretary in an interview with Rodrigo Bocardi, in the points program end. CBN.
The Butantan Institute stated, by note, that it “does not comment on information related to Sinovac’s contracts with other countries.” The statement was released after Turkish government officials announced that evidence of the CoronaVac in the country would have registered 91% effectiveness. The results obtained in Turkey were presented after preliminary analyzes and were obtained in tests with a smaller sample of volunteers.
“[Nos testes do Butantan] It did not reach 90% and although it did not reach that, lower values, these lower values already give us, which is above 50%, we do not know how much above 50%, if it was 60%, 70% or 80%, but they are at levels that allow us to reduce the impact of diseases on our population, ”added Gorinchteyn.
[ad_2]
